- ￥960 - 3360
- MedChemExpress(MCE)
- 美国
- HY-19810
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
1857417-10-7
- 规格：
10 mM * 1 mL/1 mg/5 mg/10 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥2393.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥960.0 |
| 规格： | 5 mg | 产品价格： | ￥1920.0 |
| 规格： | 10 mg | 产品价格： | ￥3360.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
MI-538
CAS No. : 1857417-10-7
MCE 国际站：MI-538
产品活性：MI-538是menin和MLL融合蛋白相互作用的抑制剂；IC50值为21 nM。
研究领域：Epigenetics
作用靶点：Epigenetic Reader Domain
In Vitro: MI-538 inhibits the proliferation of MLL leukemia cells with a GI50 of 83 nM. MI-538 shows no effect (up to 6 μM) on growth of the control cell lines HL-60 and HM-2, which do not harbor MLL translocations, demonstrating good selectivity toward MLL fusion protein transformed cells. MI-538 binds to menin with low nanomolar affinity (Kd=6.5 nM). Its potent cellular activity originates from the improved binding affinity to menin and possibly increased cell membrane permeability. Treatment with MI-538 results in strong down regulation of expression of Hoxa9 and Meis1 genes. About 100 nM 27 was sufficient to reduce by ~50% Hoxa9 expression in MLL-AF9 cells, and even more pronounced effect was seen on Meis1 expression.
In Vivo: Treatment with MI-538 results in a pronounced, about 80%, reduction in the MV4;11 tumor volume, without causing substantial signs of toxicity reflected by less than 10% reduction of the body weight. MI-538 demonstrates markedly improved exposure (area under the curve, AUC, values), Cmax (maximum compound concentration) in the blood plasma, and the lowest value of clearance. The half-life of MI-538 is about 1.6 h. MI-538 has also high oral bioavailability (~50%).
相关产品：Covalent Screening Library Plus | Bioactive Compound Library Plus | Epigenetics Compound Library | Histone Modification Research Compound Library | Anti-Cancer Compound Library | Covalent Screening Library | Reprogramming Compound Library | Anti-Blood Cancer Compound Library | Heterocyclic Compound Library | (+)-JQ-1 | Curcumin | A-485 | C646 | Revumenib | BRM/BRG1 ATP Inhibitor-1 | BI 2536 | dBET6 | MZ 1 | ARV-825 | Inobrodib | Birabresib | 666-15 | SGC-CBP30 | VTP50469 | ACBI1 | AU-15330 | ARV-771 | I-BET151 | dBET1 | dCBP-1 | ABBV-744 | Anacardic Acid | Molibresib | NSC 228155 | KG-501 | A-366 | FHD-286 | Mivebresib
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验redsky 我在mirbase查到hsa-mir-34a的序列如下： >hsa-mir-34a MI0000268 GGCCAGCUGUGAGUGUUUCUUUGGCAGUGUCUUAGCUGGUUGUUGUGAGCAAUAGUAAGGAAGCAAUCAGCAAGUAUACUGCCCUAGAAGUGCUGCACGUUGUGGGGCCC 我在ensemble查hsa-mir-34a序列及其上游(5'端）10bp序列变成
三句话读懂一篇 CNS：新疗法助力治疗女性不育；能负载活细胞的冷冻微针治疗技术；发现治疗心肌梗死新靶标，...
码 RNA MIAT（lncR-MIAT）是导致心肌梗死（MI）的危险因素。然而，lncR-MIAT 控制 MI 机制尚不明确。 2021 年 5 月 3 日，哈尔滨医科大学杨宝峰教授等研究团队在 Signal Transduction and Targeted Therapy 上发表研究论文 LncRNA MIAT impairs cardiac contractile function by acting on mitochondrial translocator protein TSPO
动物种类猴狗猫家兔豚鼠大鼠小鼠生理特征寿命（年）10~3010~158~105~85~83~42~3成年体重（公斤）5~158~202~31.5~3.00.3~0.60.2~0.40.02~0.03体温（℃）28.7~37.937.5~39.538~39.538.5~39.537.8~39.538.5~39.537~39呼吸（次/分）45~5010~3020~3050~80100~150100~150130~220心跳（次/分）140~24080~120120~140120~150230
技术资料暂无技术资料 索取技术资料
